30-day average of 21 articles · scale −100 to +100
Across 21 scored articles from Oct 16 to Nov 14, 2026 (UTC),
the average sentiment of MetLife news is Somewhat Bullish (+40)
on a scale from −100 to +100.
That is about the same as the previous 30 days (+44).
💸 The company returned approximately $1 billion to shareholders via buybacks and dividends in Q3.
🏦 Net income surged 187% year-over-year to $2.4 billion, or $3.67 per share.
🎯 MetLife remains on track to meet its full-year free cash flow and direct expense ratio targets.
💼 CEO Michel Khalaf reaffirmed confidence in the New Frontier strategy and execution discipline.
📉 Holding-company cash and liquid assets stood at $3.4 billion, within management's target range.
🚀 Broad-based operating momentum supports the case for resilient earnings across divisions.
📈 Bullish signals
📈MetLife reported record Q3 adjusted EPS of $2.85 excluding notable items, a 22% increase from the prior-year quarter and the highest in company history.
💰Revenue increased 12% to $14.1 billion with growth spanning all six business segments, demonstrating broad-based momentum.
📊Adjusted return on equity reached 19.6% excluding notable items, reflecting strong capital efficiency.
💸The company returned approximately $1 billion to shareholders through buybacks and dividends, signaling confidence in its financial position.
🏦Net income surged 187% year-over-year to $2.4 billion, driven by higher variable investment income and favorable underwriting.
🎯MetLife remains on track to meet its full-year free cash flow and direct expense ratio targets, ensuring disciplined capital management.
💼CEO Michel Khalaf reaffirmed confidence in the New Frontier strategy, citing stronger underwriting and volume growth as key drivers.
Article
MetLife Inc. reported record third-quarter adjusted earnings per share of $2.85, excluding notable items, representing a 22% increase from the prior-year quarter. This achievement marks the highest quarterly level in the company's history, driven by broad-based growth across all six business segments. Revenue increased by 12% to $14.1 billion, supported by higher variable investment income, volume growth, and favorable underwriting results.
The company reported net income of $2.4 billion, or $3.67 per share, which was up 187% year-over-year. Adjusted return on equity reached 19.6% excluding notable items, while MetLife confirmed it remains on track to meet its full-year targets for free cash flow and direct expense ratios. Holding-company cash and liquid assets stood at $3.4 billion at quarter-end, aligning with management's target range.
MetLife returned approximately $1 billion to shareholders through share repurchases and common stock dividends during the quarter, highlighting a continued focus on capital returns alongside reinvestment for growth. CEO Michel Khalaf emphasized that the results demonstrate the strength of the New Frontier strategy and the discipline of its execution, citing stronger underwriting and investment returns as key drivers.
The earnings release indicates broad operating momentum rather than growth concentrated in a single division, supporting the case for resilient earnings. MetLife stock traded at 92.45 euros on November 12, 2026, reflecting positive market sentiment following the announcement of these robust financial results and strategic confidence.
Sector and industry come from company profile data. Sentiment is the AI score of the news articles on this page, averaged per day. Not investment advice.
MetLife (MET) recently launched the Non-Qualified Assignment Flex Agreement (NQA-FA), a new deferred payment solution designed for attorneys and brokers. Unlike traditional annuities, this funding agreement offers greater flexibility regarding timing and structure, supporting features like deferred start dates, lump sums, and customized schedules. This product expansion aims to broaden MetLife's role in the legal settlements market and potentially shift investor perceptions of the company.
At a current share price of $87.40, MetLife has delivered a 27.41% return over the last 90 days and a 75.57% total shareholder return over three years, indicating building momentum around recent product launches. However, the stock trades approximately 5% below the average analyst target and is reported to have an intrinsic discount of roughly 47%. Analysts estimate a fair value of $92.80 based on detailed revenue, margin, and earnings assumptions, suggesting the stock may be undervalued despite recent gains.
The company's long-term growth strategy relies on strong premium and sales growth in high-potential international markets including Asia, Latin America, and EMEA, capitalizing on growing middle-class wealth. Additionally, MetLife is investing heavily in digital transformation through AI-driven underwriting, process automation, and embedded insurance partnerships to reduce acquisition costs and improve net margins over time.
Despite the optimistic outlook regarding product innovation and international expansion, MetLife faces specific risks tied to interest rate sensitivity and commercial mortgage credit risk. These factors could quickly challenge the current fair value narrative if market conditions deteriorate. The stock currently trades at a 16.4x P/E ratio, which is higher than the US insurance industry average of 11.2x, raising questions about whether the market is mispricing future cash flows or if the multiple already reflects growth expectations.
🚀 MetLife launches flexible deferred payment solution replacing traditional annuities.
📈 Stock gained 75.57% over three years with strong momentum.
💰 Analysts see $92.80 fair value vs current $87.40 price.
🌍 International expansion in Asia, Latin America, and EMEA drives growth.
⚠️ Risks include interest rate sensitivity and commercial mortgage credit.
🚀 MetLife launched the Non-Qualified Assignment Flex Agreement (NQA-FA), a flexible deferred payment solution for legal settlements that replaces traditional annuities.
📈 The stock has gained 27.41% over 90 days and 75.57% over three years, showing strong recent momentum.
💰 Analysts estimate a fair value of $92.80, suggesting the current price of $87.40 represents a potential discount.
🌍 International expansion in Asia, Latin America, and EMEA is expected to drive long-term revenue growth from growing middle-class wealth.
💻 Digital transformation initiatives including AI underwriting aim to reduce costs and improve net margins.
⚠️ The stock carries risks related to interest rate sensitivity and commercial mortgage credit exposure.
📊 MetLife trades at a 16.4x P/E ratio, significantly higher than the industry average of 11.2x.
Bullish Signals
Expanding into high-growth Asia and Latin America markets.
AI investments lower costs and boost net margins.
27.41% return over last 90 days.
75.57% three-year total shareholder return.
Trades below $92.80 fair value.
Risk Factors
Interest rate sensitivity impacts financial performance and valuation.
Commercial mortgage credit risk challenges fair value if markets worsen.
Stock trades at 16.4x P/E vs 11.2x industry average.
Bullish Signals
MetLife introduced the NQA-FA product to capture new value in the legal settlements market with flexible payment structures.
The company is expanding into high-growth international markets like Asia and Latin America to capitalize on increasing insurance penetration.
Significant investments in AI-driven underwriting and process automation are intended to lower acquisition costs and boost net margins.
Strong recent performance includes a 27.41% return over the last 90 days and a 75.57% three-year total shareholder return.
The stock trades below the widely followed fair value narrative of $92.80, potentially offering an entry opportunity for long-term investors.
Risk Factors
MetLife faces ongoing exposure to interest rate sensitivity, which could impact its financial performance and valuation.
The company carries commercial mortgage credit risk that could challenge the current fair value story if market conditions worsen.
The stock trades at a 16.4x P/E ratio, which is notably higher than the US insurance industry average of 11.2x.
MetLife Inc. is expanding its pet insurance portfolio by positioning Accident & Illness plans as a predictable, recurring monthly expense for cat and dog owners. The product aims to convert unpredictable veterinary bills into manageable line items through customizable coverage options, including optional wellness riders. Policies are underwritten in the US and sold directly to consumers or as voluntary benefits through employer channels, offering protection for emergencies like surgeries and diagnostics without mid-term rate jumps.
The insurer highlights key structural features such as annual benefit limits up to $25,000, reimbursement levels ranging from 70% to 90%, and deductibles starting around $50. Unlike some competitors, MetLife accepts pets of virtually any age for its core Accident & Illness plans, provided they meet underwriting rules. The product includes telehealth-style veterinary support and streamlined digital claims submission, with external reviewers noting claim processing times typically within 10 days.
MetLife is leveraging partnerships to broaden market reach, integrating offers into shelter adoption paperwork and utilizing employer benefit programs where premiums are deducted from paychecks. While monthly premiums for a young mixed-breed dog range roughly between $20 and $60 depending on breed, age, and location, the company emphasizes that rates remain stable within a 12-month term before adjusting at renewal based on pet aging or regional cost changes.
In a market showing double-digit annual growth in premiums over the past decade, MetLife views pet insurance as a strategic complementary line to its broader protection portfolio. This initiative targets younger consumers and aims to maintain brand relevance by offering coverage alongside life, disability, and dental products. The company recently traded on the NYSE at $72.45, reflecting investor interest in this fast-growing voluntary benefits category.
🐾 Covers accidents, illness, and wellness riders for predictable monthly costs.
📊 Offers up to $25k limits with 70-90% reimbursement and $50 deductibles.
🐕 Enrolls cats and dogs of any age without upper limits.
⚡ Processes claims within 10 days via mobile or web platforms.
💰 Monthly premiums range from $20 to $60 for young mixed breeds.
🐾 MetLife Pet Insurance offers Accident & Illness plans with optional wellness riders to convert unpredictable vet bills into predictable monthly expenses.
📊 Policies provide customizable annual limits up to $25,000 with reimbursement options of 70%, 80%, or 90% and deductibles starting at $50.
🐕 Enrollment is open for cats and dogs of virtually any age on core plans, removing upper age limits found in some competitor products.
💼 The product is heavily marketed through employer benefits channels as a voluntary benefit deducted from employee paychecks.
⚡ External reviewers note fast claim processing times, typically within 10 days after submission via mobile or web platforms.
🏥 Coverage includes exams, diagnostics, surgeries, hospitalization, prescription meds, and alternative therapies like acupuncture when recommended.
📈 MetLife targets the growing US pet insurance market which has seen double-digit annual premium growth over the last decade.
💰 Sample monthly premiums for a young mixed-breed dog range from roughly $20 to $60 depending on breed, age, and ZIP code.
🔄 Rates are stable within a 12-month policy term but may increase at renewal as the pet ages or regional costs rise.
🤝 Partnerships with shelters and rescue organizations allow for promotional offers during adoption paperwork conversion.
Bullish Signals
Accepts pets of virtually any age for core plans.
Includes optional wellness riders for routine care customization.
Fast claim processing times, typically within 10 days.
Offers free 24/7 telehealth veterinary support to policyholders.
Integrates coverage into shelter adoption paperwork for new parents.
Bullish Signals
MetLife accepts pets of virtually any age for its core Accident & Illness plans, making it accessible to owners of senior animals without upper age limits.
The product includes optional wellness riders for routine care like vaccinations and checkups, allowing customers to customize their recurring expense level.
External reviewers highlight fast claim processing times, typically within 10 days, reducing friction for policyholders filing smaller claims.
MetLife offers telehealth-style veterinary support at no additional cost, providing 24/7 access to virtual care partners for policyholders.
The company integrates coverage into shelter adoption paperwork, offering new pet parents a pathway to convert trial periods into paid recurring policies.
Pet insurance is identified as one of the fastest-growing voluntary benefits categories in employer-sponsored plans, indicating strong market demand.
MetLife Inc. (MET) shares are trading near record highs, closing at approximately $88.84 on the NYSE following a powerful multi-month rally that has delivered roughly a 30% gain over the past twelve months and more than 5% in the last week. This surge has prompted Morningstar to downgrade its rating from 3 stars to 2 stars, signaling that the stock is now considered overvalued relative to its fair value estimate as most expected fundamental improvements appear already priced in.
Analyst consensus data suggests limited near-term upside, with a price target near $92 implying only about 3.5% potential gain from current levels, while some fair-value models point to an intrinsic value closer to $75 per share. The rally is driven by multiple expansion rather than earnings forecast revisions, supported by a higher interest rate environment that boosts investment income on MetLife's massive fixed-income portfolio and its conservative debt-to-equity ratio of roughly 0.7 times.
MetLife differentiates itself from peers like Lincoln National through a diversified business mix across group benefits, retirement, and international operations in regions including the Gulf, Latin America, and Asia. While these structural strengths—such as lower leverage and global reach—justify part of the valuation premium, the stock is now viewed by some as a mature rerating play where future performance hinges on maintaining high return on equity and navigating potential multiple compression if macro tailwinds fade.
The company continues to invest in technology and operational efficiency, evidenced by hiring for roles in third-party risk management and digital capabilities, alongside strategic partnerships like the one with Orange Jordan in the Gulf region. However, investors face a choice between MetLife's perceived quality at a higher price or cheaper peers with more pronounced risks, making upcoming earnings releases, interest rate developments, and capital deployment strategies critical catalysts for determining whether the current valuation can be sustained.
📈 Shares near $88.84 all-time high after 30% annual gain.
⭐ Morningstar downgraded to 2 stars citing overvaluation.
💰 High interest rates boost fixed-income portfolio earnings.
🛡️ Conservative 0.7 debt-to-equity ratio offers peer flexibility.
🌍 Global footprint diversifies earnings across key regions.
📈 MetLife shares closed near an all-time high of $88.84 after a roughly 30% gain over the past year and a 5% advance in the last week.
⭐ Morningstar downgraded MetLife from 3 stars to 2 stars, classifying it as overvalued relative to its intrinsic worth estimate.
📊 Consensus analyst price targets hover around $92, suggesting only modest upside of approximately 3.5% from current levels.
💰 Elevated interest rates support higher investment income on MetLife's fixed-income portfolio, a key earnings driver for life insurers.
🛡️ MetLife maintains a conservative debt-to-equity ratio of roughly 0.7 times, providing flexibility compared to more highly geared peers.
🌍 The company operates globally with significant footprints in the Gulf, Latin America, and Asia to diversify earnings streams.
💻 Recent hiring focuses on technology services and third-party risk management to enhance digital platforms and operational efficiency.
🤝 MetLife partnered with Orange Jordan to offer life insurance via a digital e-wallet app, expanding reach in emerging markets.
⚖️ Valuation metrics suggest the stock trades at a premium to peers like Lincoln National due to diversification and lower leverage.
📉 Fair-value models indicate a potential intrinsic value closer to $75 per share, highlighting a gap between market price and modeled worth.
🏢 Group benefits and retirement products provide steady fee and risk revenue, offsetting volatility in investment income.
🔮 Future performance depends on maintaining high return on equity and sustaining strong capital returns without eroding balance sheet metrics.
Bullish Signals
Shares up ~30% over past twelve months.
Higher rates boost investment income on fixed portfolio.
Conservative debt-to-equity ratio of approximately 0.7 times.
Diversified operations across US, Gulf, Latin America, Asia.
Risk Factors
Morningstar downgraded stock to 2-star rating.
Analyst targets near $92 imply only 3.5% upside.
Intrinsic value models suggest fair price of $75.
Post-pandemic rate reset benefits likely already priced in.
Trading at premium to peers raises performance bar.
Bullish Signals
MetLife shares are trading near record highs with a roughly 30% gain over the past twelve months, reflecting strong market confidence.
The company benefits from a higher interest rate environment that boosts investment income on its massive fixed-income portfolio.
MetLife maintains a conservative debt-to-equity ratio of approximately 0.7 times, offering greater flexibility than many peers.
Diversified operations across the US, Gulf, Latin America, and Asia reduce reliance on any single geography or product line.
Strategic partnerships like the one with Orange Jordan demonstrate effective distribution models in emerging markets.
Investment in technology and digital capabilities supports long-term efficiency gains and competitiveness in customer engagement.
Group benefits and retirement products provide a steady stream of fee income that stabilizes earnings volatility.
MetLife's global reach allows it to offset regional fluctuations in claims experience and economic conditions.
Risk Factors
Morningstar has downgraded MetLife to a 2-star rating, signaling the stock is overvalued relative to its fair value estimate.
Consensus analyst price targets near $92 imply limited upside of only about 3.5% from current levels of roughly $88.84.
Fair-value models suggest an intrinsic value closer to $75 per share, indicating the stock trades meaningfully above modeled worth.
Much of the benefit from post-pandemic rate resets may already be embedded in share prices for large diversified players like MetLife.
Valuation metrics show MetLife trading at a premium to peers, raising the bar for future fundamental performance to justify multiples.
If interest rates normalize downward or competitive pressures intensify, valuations could compress across the industry affecting higher-multiple names more.
MetLife reported strong first-quarter 2026 results with adjusted earnings per share rising 23% to $2.42 and a return on equity of 17%, reflecting robust core performance. The author, a financial analyst specializing in fixed income and preferred stocks, highlights the company's fixed-income preferred shares as particularly compelling, noting that Series F offers yields near 6.5% with payout ratios under 4%. This combination provides rare quality and safety for investors seeking income-generating assets.
Common shares are trading at approximately 8.5 times forward earnings, which the author considers fair value with limited near-term upside potential. However, total equity returns are estimated to approximate 8% annually through a combination of buybacks and dividends. While risks such as commercial mortgage exposure and volatile alternative investment income exist, preferred dividend coverage remains exceptionally strong, supporting the credit quality of these hybrid securities.
📈 MetLife Q1 2026 EPS rose 23% to $2.42 with ROE at 17%.
💰 Series F preferreds offer ~6.5% yields with payout ratios under 4%.
⚠️ Key risks include commercial mortgage exposure and volatile alternative investment income.
📈 MetLife reported strong Q1 2026 results with adjusted EPS rising 23% to $2.42 and ROE reaching 17%.
💰 Fixed-income preferreds, particularly Series F, are highlighted as compelling with yields near 6.5% and payout ratios under 4%.
📉 Common shares trade at a fair 8.5x forward P/E with limited near-term upside but offer approximate 8% annual total equity returns.
🔄 Total equity returns for common stock are driven by buybacks and dividends rather than significant capital appreciation.
⚠️ Key risks identified include exposure to commercial mortgages and volatile alternative investment income.
✅ Preferred dividend coverage remains exceptionally strong despite the noted risks in the broader portfolio.
📊 The author is a financial analyst specializing in fixed income, credit analysis, and income-generating assets.
🔍 The article focuses on rigorous credit analysis of preferred stocks, bonds, REITs, BDCs, and other fixed income instruments.
🎯 Investment approach is fundamentally driven by risk-adjusted returns and identifying market mispricings relative to credit quality.
📋 Analyst disclosure indicates a beneficial long position in MET.PR.F shares through stock ownership or derivatives.
🛡️ Seeking Alpha's standard disclaimer notes that past performance does not guarantee future results and no specific investment advice is given.
🏢 The author has professional experience analyzing structured credit instruments and valuing corporate balance sheets.
📉 Interest rate volatility is a key factor the author monitors within the fixed income and hybrid markets.
📅 MetLife stock traded around $84 at the time of the article's publication in June 2026.
🏦 The analysis emphasizes factors like balance sheet structure, asset coverage ratios, and preferred redemption schedules.
Bullish Signals
MetLife Q1 2026 adjusted EPS rose 23% to $2.42.
Company achieved robust ROE of 17% with solid core performance.
Fixed-income preferreds Series F yield near 6.5% under 4% payout.
MetLife (MET) is currently rated as a Zacks Rank #3 (Hold) with a forward P/E of 7.97X, which is below the industry average of 8.77X, and carries a Value Score of A. The company has a market capitalization of $53.3 billion and operates as an insurance-based global financial services firm offering protection and investment products to individual and institutional customers. Shares have grown 4.5% over the past year, outperforming the industry's 2.3% decline.
The consensus estimate for MetLife's 2026 earnings is $9.96 per share, representing a 12.8% year-over-year increase, while revenues are pegged at $79.1 billion with a 0.3% rise. The company beat earnings estimates in three of the past four quarters with an average surprise of 2.4%. Growth is supported by its global franchise and diversified business mix, with total premiums rising 3.4% year over year in the first quarter of 2026 and revenues increasing 2.7% during the same period.
MetLife is entering the next phase of its New Frontier strategy, focusing on translating market leadership into sustained earnings growth by leveraging favorable demographic trends like an aging population and rising retirement planning needs. The company is investing in technology modernization and artificial intelligence to improve customer experiences and streamline processes, while strengthening asset management capabilities through the integration of PineBridge Investments. Financially, MetLife holds $22.7 billion in cash and cash equivalents as of March 31, 2026, far exceeding its short-term debt of $404 million, supporting shareholder returns through share repurchases and dividends with a yield of 2.9%.
However, investors should monitor volatile variable investment income, which was below target at $1.5 billion in 2025 and $518 million in the first quarter of 2026, remaining sensitive to private equity and real estate markets. Additionally, MetLife's return on invested capital (ROIC) is 1.8%, below the industry average of 2.2%, indicating relatively weaker capital efficiency. The article also highlights other insurance stocks with Zacks Rank #1 ratings, such as Octave Specialty Group, Pelagos Insurance Capital, and The Hanover Insurance Group, suggesting they may offer stronger growth potential compared to MetLife's current hold rating.
📈 MetLife stock gained 4.5% annually, outperforming the industry's decline.
💰 Forward P/E of 7.97X is below the sector average of 8.77X.
📅 Analysts project 2026 earnings growth of 12.8% to $9.96 per share.
💵 Revenue expected to reach $79.1 billion with modest 0.3% growth.
⚠️ ROIC of 1.8% trails the industry average of 2.2%.
📈 MetLife stock has gained 4.5% over the past year, outperforming the industry's 2.3% decline.
💰 The company carries a Zacks Rank #3 (Hold) with a forward P/E of 7.97X versus an industry average of 8.77X.
📅 Analysts project 2026 earnings of $9.96 per share, representing a 12.8% year-over-year increase.
💵 Revenue is expected to reach $79.1 billion in 2026, implying a modest 0.3% growth.
📊 MetLife beat earnings estimates in three of the past four quarters with an average surprise of 2.4%.
🌍 Total premiums rose 3.4% year-over-year in Q1 2026, driven by strong sales in Japan, Korea, and Latin America.
📉 Variable investment income was volatile, reaching $518 million in Q1 2026 against a target of $1.6 billion for the full year.
⚠️ Return on invested capital (ROIC) stands at 1.8%, which is below the industry average of 2.2%.
💧 The company holds $22.7 billion in cash and equivalents, significantly exceeding its short-term debt of $404 million.
🔄 MetLife repurchased $950 million worth of shares in Q1 2026 and April 2026 combined.
📈 Its dividend yield of 2.9% is higher than the industry average of 2.6%.
🤖 The firm is leveraging artificial intelligence to improve customer experiences and streamline operational processes.
🏦 MetLife integrated PineBridge Investments to strengthen its asset management capabilities.
🌐 The company is entering a new phase of its "New Frontier" strategy focused on sustained earnings growth.
⚠️ Investors are advised to monitor sensitivity to private equity and real estate markets regarding investment income.
📉 Some analysts suggest better-ranked alternatives in the insurance space, such as Octave Specialty Group (Zacks Rank #1).
Bullish Signals
Strong growth driven by higher premiums, cost-cutting, and acquisitions.
Trades at 7.97X forward P/E vs 8.77X industry average.
Value Score A with shares up 4.5% vs industry down 2.3%.
2026 earnings pegged at $9.96/share, a 12.8% rise.
Beat estimates in 3 of past 4 quarters.
Total premiums rose 3.4% YoY in Q1 2026.
New Frontier strategy targets sustained earnings growth.
$22.7B cash exceeds $404M short-term debt.
Share buybacks totaled $950M in Q1-April 2026.
Dividend yield of 2.9% beats industry average.
Risk Factors
Variable income volatile, missed $1.5B target in 2025.
ROIC at 1.8% trails industry average of 2.2%.
Zacks Rank #3 suggests neutral stance on stock.
Bullish Signals
MetLife is well-poised for growth driven by higher premiums, cost-cutting efforts, strong cash generation, and strategic acquisitions.
The company trades at a forward P/E of 7.97X, which is lower than the industry average of 8.77X, indicating potential value.
MetLife holds a Value Score of A and has outperformed the industry with shares growing 4.5% over the past year versus an industry fall of 2.3%.
The consensus estimate for 2026 earnings is pegged at $9.96 per share, representing a 12.8% year-over-year rise that has been revised upward recently.
MetLife beat earnings estimates in three of the past four quarters with an average surprise of 2.4%, demonstrating consistent performance.
Total premiums rose 3.4% year over year in Q1 2026, supported by robust sales growth in Japan, Korea, and Latin America.
The company is entering the next phase of its New Frontier strategy to translate market leadership into sustained earnings growth.
MetLife has a strong liquidity position with $22.7 billion in cash and cash equivalents as of March 31, 2026, far exceeding short-term debt of $404 million.
The company returned capital to shareholders by buying back common shares worth $750 million in Q1 2026 and an additional $200 million in April 2026.
MetLife's dividend yield of 2.9% remains higher than the industry average of 2.6%, offering attractive income potential.
Risk Factors
MetLife's variable investment income has been volatile and remained below target at $1.5 billion in 2025 and $518 million in the first quarter of 2026.
The company's return on invested capital (ROIC) is 1.8%, which is below the industry average of 2.2%, indicating relatively weaker capital efficiency.
MetLife carries a Zacks Rank #3 (Hold), suggesting investors should remain neutral rather than bullish on the stock.
The provided text appears to be raw source code from a financial news website featuring MetLife (NYSE: MET), including extensive HTML and CSS styling information rather than a readable news article. It contains no substantive reporting, earnings data, stock price movements, or corporate announcements regarding the company. The content is primarily composed of style definitions for layout, typography, buttons, and responsive design elements used by the FinancialContent platform to display financial news feeds. Without actual text content summarizing a specific news event, analyst ratings, or operational updates, there is no substantive information about MetLife beyond the ticker symbol mentioned in the page title.
🔒 Source material contains only HTML and CSS code.
🚫 No financial data or company news is present.
❌ A factual summary cannot be generated.
🔒 The provided content consists entirely of HTML and CSS styling code rather than a news article.
🚫 No financial updates, stock performance, or company news about MetLife (NYSE:MET) are present in the text.
❌ Consequently, no factual bullet-point summary can be generated from this source material.
Bullish Signals
MetLife (NYSE:MET) stock page is available for tracking its latest financial news and market performance.
The article provides a dedicated section to track MetLife's stock price movements with positive change indicators highlighted in green.
Navigation features allow users to filter and access specific news updates relevant to the insurer's business development.
Risk Factors
The provided text contains only CSS styling code and website layout instructions, with no actual news article content about MetLife (NYSE:MET).
No financial data, risks, or negative information can be extracted from this source material.
MetLife, Inc. (NYSE: MET) is featured in a Seeking Alpha stock news article as of March 27, 2026, where the company's stock price is reported at $67.70 with a post-market trading value of $70.39. The data indicates a significant market movement within the day, showing an initial drop of $2.04 or -2.93%, followed by a rebound of $2.69 or +3.97% in post-market trading at 6:14 PM. MetLife operates as a financial services company providing insurance, annuities, employee benefits, and asset management services globally, organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe the Middle East and Africa, and MetLife Holdings.
The company offers a comprehensive range of products including life, dental, disability, accident and health, vision, and pet insurance, alongside fixed, indexed-linked, and variable annuities. Its operations span from New York to international markets across Asia, Latin America, Europe, the Middle East, and Africa. MetLife was incorporated in 1999 and is based in New York, while Seeking Alpha, which hosts this stock information, was founded in 2004 and provides financial research tools and community insights for investors. The article also notes that access to certain features like full news stories, analysis, transcripts, and SEC filings may require a Pro subscription with Seeking Alpha Premium or PRO tiers.
Contact details for Seeking Alpha are provided, including a telephone number of +1-347-509-6837 and an email address at [email protected]. The publisher is based at 244 5th Ave, New York, NY 10001, US, with online presence including social media links to Facebook, YouTube, LinkedIn, Instagram, X (formerly Twitter), TikTok, Spotify, and Apple Podcasts for their Wall Street Breakfast show. The content emphasizes that Seeking Alpha bridges the gap between financial information and actionable insight for millions of investors globally, offering ratings, charting tools, and analysis on thousands of stocks across various asset classes.
📉 Stock fluctuated between a $67.70 dip and a $70.39 post-market gain.
🏢 MetLife is a New York-based financial services corporation serving global markets.
💼 The firm offers core products like insurance, annuities, and asset management.
📉 MetLife stock closed at $67.70 in after-hours trading, down 2.93%.
📈 Post-market trading pushed the share price up to $70.39, representing a 3.97% gain.
🏢 MetLife Inc is a financial services company headquartered in New York.
🌍 The company operates globally across six business segments including Asia and Latin America.
💼 Core products include insurance, annuities, employee benefits, and asset management services.
📅 MetLife was incorporated in 1999 and serves institutional and individual clients.
Bullish Signals
No positive aspects could be extracted from the provided article content.
Risk Factors
The stock is currently down 2.93% in post-market trading, indicating negative sentiment following the 4:00 PM close at $67.70.
Post-market price has recovered to $70.39 but remains volatile with a +3.97% gain that contradicts the earlier drop, suggesting uncertainty around pricing.
MetLife's common shares and preferred stock receive a bullish recommendation from an investment group leader based on the company's robust adjusted income and strong balance sheet health. The article highlights that MetLife maintains a low preferred dividend payout ratio and holds $24.5 billion in common equity, providing significant downside protection for preferred shareholders. Specifically, Series F fixed-rate preferreds are rated as a buy due to their high current yield of 6.35%, while Series A floating-rate preferreds are held with a "hold" rating pending further increases in SOFR, offering attractive yields between 5.45% and 5.5% if short-term rates rise. The common shares are also rated as a buy for their potential capital gains and dividend income within the author's recommended 5-7 year investment horizon.
The investment thesis focuses on MetLife's strategic positioning in group benefits with expanding exposure to markets in the US, Japan, and Great Britain. Despite being described as one of the largest financial services companies, this analysis comes from a writer specializing in European small-cap ideas who views MetLife as a core holding for dividend and growth mix portfolios. The author maintains a beneficial long position specifically in MET.PR.F through stock ownership or options and discloses having written put options on common shares without holding an equity position at the time of publication.
The article includes standard financial disclosures noting that the author operates independently of Seeking Alpha as a third-party contributor and is not compensated by the companies mentioned. The content emphasizes that past performance does not guarantee future results and explicitly states this is not formal investment advice, serving instead as actionable research for investors seeking high-quality dividend and growth opportunities with continuous cash flow generation.
📈 Analysts rate MetLife common shares and Series F preferreds as "buy" targets.
💰 Strong adjusted income supports equity and debt investment optimism.
🛡️ Preferred holders enjoy low payout ratios backed by $24.5B in equity.
🔍 Floating-rate Series A offers yields between 5.45% and 5.5% for rising rates.
⏸️ Series A preferreds hold pending significant increases in SOFR benchmark rates.
🏦 MetLife (MET) is recommended for long positions on common shares and its 6.35% fixed-rate preferred stock (Series F).
💰 The company reported robust adjusted income, which supports the bullish outlook for both equity and debt investments.
🛡️ Preferred holders benefit from a low dividend payout ratio and $24.5B in common equity acting as downside protection.
📊 Series A floating-rate preferreds offer yields between 5.45% and 5.5%, suitable if short-term interest rates increase.
⭐ Analyst rates MET common shares and Series F preferreds with a "buy" recommendation.
⏸️ The Series A preferred stock maintains a "hold" rating pending a significant rise in SOFR benchmark rates.
👤 The author holds put options on MET common shares but has no current direct equity position.
📝 This article was published on May 24, 2026, by the Investment Doctor Investing Group Leader.
🌍 MetLife focuses on group benefits while expanding exposure to markets in the US, Japan, and Great Britain.
⚠️ Disclosure indicates the author has a beneficial long position in MET.PR.F stock or derivatives.
🔍 Readers are encouraged to join the European Small-Cap Ideas group for exclusive actionable research.
Bullish Signals
MetLife delivers robust adjusted income, supporting a bullish stance on common shares and fixed-rate preferreds.
MET's preferred dividend payout ratio remains low, with $24.5B in common equity providing strong downside protection for preferred holders.
Series A floating-rate preferreds yield 5.45%-5.5%, offering attractive returns if short-term rates rise.
Fixed-rate Series F offers a higher current yield, making it an attractive investment option.
The Investment Doctor rates MetLife common and Series F preferreds as a 'buy', indicating confidence in their potential.
MetLife is one of the largest financial services companies with a specific focus on group benefits, providing stability.
The company is improving its exposure to the US, Japan, and Great Britain, diversifying its revenue streams across multiple markets.
MetLife, Inc. (NYSE: MET) announced on May 15, 2026, the declaration of quarterly dividends for three distinct classes of preferred stock for the second quarter of 2026. The company declared a dividend of $0.31190376 per share on its Series A floating rate non-cumulative preferred stock (NYSE: MET PRA), which has a liquidation preference of $25 per share. Additionally, MetLife declared a quarterly dividend of $0.3515625 per depositary share for its 5.625% non-cumulative Series E preferred stock (NYSE: MET PRE), representing shares with a $25,000 liquidation preference and issued as 1/1,000th interest units.
The third dividend declaration covers the company's 4.75% non-cumulative Series F preferred stock (NYSE: MET PRF), set at $0.296875 per depositary share with a $25,000 liquidation preference, also structured as depositary shares representing 1/1,000th interest. All three dividends are scheduled to be payable on June 15, 2026, to shareholders of record as of May 31, 2026. The press release notes a slight discrepancy in the record date listing where it states Friday, May 29, 2026, but immediately follows with Sunday, May 31, 2026, identifying that as the official record date for this fiscal quarter.
This announcement is a routine corporate finance update regarding preferred equity holders rather than an assessment of MetLife's common stock performance or general financial results. The release serves primarily to inform specific bond-like investors about their upcoming cash distributions and confirms the company's ongoing commitment to servicing its preferred stock obligations. Contact information for media inquiries was provided through Steve LaMarca and investor relations through John Hall, while a forward-looking statement disclaimer noted that future results depend on assumptions involving risks detailed in SEC filings.
🗓️ Preferred dividends declared May 15, 2026, payable June 15, 2026.
💰 Series A pays $0.31; Series E/ F pay $0.35/$0.30 per share.
🏢 Record date is May 29, 2026 (closing Friday May 31).
📅 MetLife announced the declaration of second quarter 2026 preferred stock dividends on May 15, 2026.
💰 A quarterly dividend of $0.31190376 per share will be paid on floating rate non-cumulative preferred stock Series A (NYSE: MET PRA).
💵 Holders of Series E 5.625% non-cumulative preferred stock will receive $351.5625 per share, payable via depositary shares at $0.3515625 each (NYSE: MET PRE).
📉 Preferred stock Series F, with a 4.75% rate, carries a quarterly dividend of $296.875 per share, distributable to depositary share holders as $0.296875 (NYSE: MET PRF).
🗓️ All declared dividends are scheduled for payment on June 15, 2026.
📝 The record date for determining eligible shareholders is set for Friday, May 29, 2026.
⚠️ A Sunday record closing date of May 31, 2026 is noted in the announcement details.
🏢 MetLife Inc. (NYSE: MET) is one of the world's leading financial services companies founded in 1868.
🌍 The company operates in over 40 global markets including the US, Asia, and Europe.
⚖️ All preferred stock series mentioned are classified as non-cumulative with a $25 or $25,000 liquidation preference.
🔗 Further corporate information is available at the official MetLife website.
⛔ Forward-looking statements in the release carry standard risk and uncertainty disclaimers regarding future results.
📞 Media inquiries are directed to Steve LaMarca via phone or email provided in the press release.
📢 Investor relations contact John Hall is listed for specific investor questions.
Bullish Signals
MetLife declares quarterly dividends across three preferred stock series.
Series A pays $0.312 reflecting strong cash flow generation.
Series E offers a robust $0.352 dividend on a 5.6% coupon.
Series F provides a competitive $0.297 payout reflecting a 4.75% rate.
June 15, 2026 payment dates offer predictable income streams.
Risk Factors
Dividend record date of May 31, 2026 falls on a weekend.
Company omitted quarterly common stock results from announcement.
Bullish Signals
MetLife successfully declared quarterly dividends across three preferred stock series, reinforcing its commitment to returning capital to investors.
The company announced a quarterly dividend of $0.31190376 on Series A floating rate preferred stock, demonstrating strong cash flow generation for its debt obligations.
Holders of Series E preferred stock will receive a robust quarterly dividend of $0.3515625 per depositary share based on a stable 5.625% coupon rate.
Series F preferred shareholders are set to receive a competitive quarterly payout of $0.296875 per depositary share reflecting the underlying 4.75% interest rate.
Dividends scheduled for payment on June 15, 2026, provide predictable income streams for investors meeting the May 29/31 record dates.
MetLife continues to leverage its legacy as a leading global financial services company with operations in over 40 markets since its founding in 1868.
Risk Factors
The dividend record date is listed as Sunday, May 31, 2026, which appears contradictory since weekends are typically non-business days and standard corporate actions usually occur on business days.
MetLife has not disclosed its quarterly common stock results, focusing the announcement solely on preferred stock dividends which may indicate weak underlying earnings performance.
MetLife (MET) reported first-quarter earnings that beat Wall Street expectations for both revenue and non-GAAP profit, yet the stock price declined from $80.16 to $78.30 in response to the results. CEO Michel Khalaf highlighted strong premium volumes across all operating segments, disciplined expense control, and favorable investment returns in private equity and venture capital as key drivers. Specifically, growth was fueled by Group Life mortality trends and broad-based international sales, while the company successfully absorbed additional expenses related to integrating asset manager PineBridge through its overall cost discipline.
Although management praised adjusted earnings ahead of last year for every operating business segment, market sentiment appears cautious regarding future execution risks. StockStory analysts have identified three primary areas to monitor in upcoming quarters: the pace of international sales growth in Asia and Latin America, the realization of operating synergies and expense improvements from the PineBridge integration, and management's ability to sustain favorable underwriting margins in Group Benefits and Retirement & Income Solutions. Additionally, ongoing regulatory developments in Japan and the effectiveness of technology-driven cost savings will be critical indicators for MetLife's execution strategy going forward.
📈 MetLife beat expectations with strong revenue, profit, and top-line growth.
👔 Adjusted earnings exceeded last year across all operating business segments.
💰 Growth stemmed from premiums, expense discipline, and favorable investment returns.
📉 Stock price dropped despite positive results following the earnings announcement.
📈 MetLife's first quarter results beat Wall Street expectations for both revenue and non-GAAP profit.
💰 Growth was driven by strong premium volumes, disciplined expense control, and favorable investment returns in private equity and venture capital.
👔 CEO Michel Khalaf highlighted that adjusted earnings were ahead of last year across all operating business segments with top line growth.
📉 Despite outperforming expectations, the stock price dropped from $80.16 to $78.30 following the earnings announcement.
🔧 Integration of asset manager PineBridge added to expenses, though management noted these costs were successfully absorbed through overall cost discipline.
🌍 Positive factors included favorable trends in Group Life mortality and broad-based international sales growth.
📊 The StockStory team plans to monitor future international sales growth, specifically in Asia and Latin America.
🤖 Management will be watched for the realization of operating synergies and expense improvements from the PineBridge integration.
💰 Underwriting margins in Group Benefits and Retirement & Income Solutions will be closely tracked for sustainability.
⚖️ Ongoing regulatory developments in Japan and the effectiveness of technology-driven cost savings are key indicators for execution.
Bullish Signals
MetLife beat Wall Street revenue and profit expectations.
Growth driven by strong premium volumes across all segments.
Adjusted earnings exceeded last year with top line growth.
Favorable Group Life mortality trends boosted topline results.
PineBridge integration costs absorbed via strict cost discipline.
Investment returns remain favorable, especially in private equity.
Japan regulations pose execution and profit risks.
Technology cost savings remain unproven.
Sales growth pace in Asia faces scrutiny.
Bullish Signals
MetLife's Q1 results saw the company outperform Wall Street's revenue and non-GAAP profit expectations.
Management attributed growth to strong premium volumes across all major operating segments.
CEO Michel Khalaf stated that adjusted earnings were ahead of last year for all operating business segments with across-the-board top line growth.
Favorable trends in Group Life mortality contributed to the positive topline.
MetLife has successfully absorbed increased expenses from the integration of asset manager PineBridge due to overall cost discipline.
The company is maintaining favorable investment returns, particularly in private equity and venture capital.
Risk Factors
MetLife's stock price dropped from $80.16 to $78.30 following the earnings release, indicating negative market sentiment despite beating expectations.
The integration of asset manager PineBridge has contributed to increased expenses, introducing uncertainty around future cost synergies.
Future performance will depend on the ability to sustain favorable underwriting margins specifically in Group Benefits and Retirement & Income Solutions segments.
Ongoing regulatory developments in Japan present a specific external risk that could impact execution and profitability.
Management faces pressure to demonstrate effective technology-driven cost savings, which remains unproven.
Analysts are scrutinizing the pace of international sales growth, particularly in complex emerging markets like Asia and Latin America.
MetLife Inc. (NYSE: MET) posted robust first-quarter earnings with adjusted profits reaching $1.6 billion, or $2.42 per share, marking an 18% increase year over year and beating expectations for all business segments. CEO Michel Khalaf attributed this performance to broad-based growth across operating units, favorable underwriting trends, and disciplined capital management under the New Frontier strategy. While net income was lower at $1.1 billion due to investment losses in fixed maturity portfolios, the company maintained liquidity near its target range and returned approximately $1.1 billion to shareholders through dividends and buybacks, increasing the dividend by 4.4%.
The Group Benefits segment drove significant growth with adjusted earnings up 19% to $439 million, helped by exceptional life mortality trends driven by a light flu season and potential impacts from GLP-1 drugs. Retirement and Income Solutions also performed well, reporting adjusted earnings of $451 million as the company rotated assets linked to large pension risk transfer inflows, keeping its investment spread at 119 basis points. International operations showed strong momentum, particularly in Asia where earnings jumped 31% led by growth in Japan and Korea, while Latin America and EMEA regions delivered solid gains despite some tax headwinds in Mexico.
📈 MetLife Q1 adjusted earnings jumped 18% to $2.42 per share.
🏆 ROE reached 17%, beating targets while expenses stayed ahead of schedule.
🌍 International sales surged significantly in Asia, Japan, and Korea regions.
💸 Net income dipped due to investment losses but dividends still rose.
📈 MetLife reported Q1 adjusted earnings of $1.6 billion, or $2.42 per share, representing an 18% year-over-year increase.
💰 Adjusted return on equity reached 17%, which sits at the top end of the company's target range of 15% to 17%.
📉 The direct expense ratio improved to 11.9%, beating the 2026 annual target of 12.1%.
💸 Net income was $1.1 billion, or $1.74 per share, impacted by net investment losses from fixed maturity trading and private equity sales.
🤝 MetLife returned approximately $1.1 billion to shareholders via capital distributions and increased its dividend by 4.4%.
🏢 Group Benefits adjusted earnings rose 19% year-over-year to $439 million, driven by exceptional life mortality ratios of 80.1%.
📈 Retirement and Income Solutions earnings climbed 11% to $451 million, fueled by a total investment spread of 119 basis points.
🌏 International operations performed strongly with Asia earnings up 31%, Latin America up 5%, and EMEA rising 33%.
🇯🇵 Japan sales increased 26% on a constant currency basis, driven by foreign-exchange strength and new corporate accident products.
🇰🇷 Korea sales grew 44% thanks to dollar-denominated products and strength in won products amid rising equity markets.
📉 Latin America earnings declined 9% on a constant currency basis due to Mexico's VAT change and less favorable tax conditions.
⚠️ Middle East operations have not yet seen material impact, though management advises waiting for stabilization before assuming further effects.
💼 MetLife Investment Management reported $47 million in adjusted earnings following the full integration of the PineBridge acquisition.
🏥 Executives attributed part of the strong performance to favorable working-age mortality trends and light flu seasons.
💰 CFO John McCallion noted that persistency improved broadly across segments, particularly in dental products.
Bullish Signals
Adjusted earnings rose 18% YoY to $1.6 billion.
ROE reached 17% while dividends increased 4.4%.
Group Benefits earnings grew 19% year-over-year.
Asia revenues surged 31% and EMEA up 33%.
Group Life mortality ratio hit 80.1%, beating targets.
Group Benefits sales climbed 15% with double-digit product growth.
Asia sales jumped 22%; Korea sales soared 44%.
Investment Management earnings doubled to $47 million.
Executives praised broad-based growth and disciplined capital.
Risk Factors
Net investment losses from trading activity and private equity sales.
Core spread declined 4 basis points as assets rotated.
Latin America earnings dropped 9% due to Mexico tax changes.
Mortality favorability driven by temporary COVID effects or GLP-1 drugs.
Sustainable underwriting trends may be questioned by one-time Japan product launches.
MetLife Investment Management shows limited history after PineBridge acquisition.
Bullish Signals
MetLife reported strong Q1 with adjusted earnings of $1.6 billion, representing an 18% year-over-year increase and an adjusted ROE of 17%.
The company returned approximately $1.1 billion to shareholders, increased its dividend by 4.4%, and maintained liquidity at the top of its target range.
Core businesses showed broad growth with Group Benefits earnings up 19% year-over-year and Retirement and Income Solutions earnings increasing 11%.
Adjusted premiums, fees, and other revenues rose 10% year-over-year, driven by strong performance in Asia (up 31%) and EMEA (up 33%).
Life mortality was exceptional with a Group Life mortality ratio of 80.1%, beating the company's target range.
Group Benefits sales increased 15%, while persistency improved broadly, particularly in dental, and voluntary product growth remained in double digits.
Asia sales increased 22% on a constant currency basis, with Japan sales rising 26% and Korea sales increasing 44%.
MetLife Investment Management adjusted earnings more than doubled to $47 million following its first fully integrated quarter post-PineBridge acquisition.
Executives highlighted broad-based growth across operating businesses, favorable underwriting trends, and disciplined capital management under the New Frontier strategy.
Risk Factors
The insurer reported net investment losses driven by normal trading activity within its fixed maturity portfolio and a modest loss tied to the sale of private equity limited partnership interests.
MetLife's core spread excluding variable investment income declined 4 basis points sequentially as the company rotated assets following large fourth-quarter pension risk transfer inflows.
Latin America adjusted earnings decreased 9% on a constant currency basis due to Mexico's value-added tax change and less favorable taxes, despite overall revenue growth.
Group Life mortality favorability could be driven by temporary factors like COVID-related pull-forward effects or the impact of GLP-1 drugs rather than sustainable underwriting trends.
Any mortality improvements that persist are expected to flow back into pricing gradually over years rather than quarters, potentially delaying immediate earnings benefits.
Asia growth in Japan was significantly boosted by a new corporate accident and health product launched during the quarter, raising questions about the sustainability of such one-time launches.
MetLife Investment Management reported adjusted earnings of $47 million following its first fully integrated quarter after the PineBridge acquisition, indicating limited historical data for comparison.
MetLife stock (ticker MET) experienced a decline of 2.68% in May 2026, trading at $78.08 as of early in the month according to data from StockTitan. Algorithmic analysis identified bearish positioning and mid-channel oscillation patterns, with weak near-term sentiment potentially catalyzing further downward pressure on the price. This recent movement reflects broader market dynamics affecting major US insurers, though the company maintains a top-tier position within the sector with a market capitalization of approximately $50 billion.
The article outlines MetLife's business model which relies on underwriting discipline, investment income from its general account, and fee-based revenues. Its primary segments include Group Benefits for US employers covering dental, disability, accident, and life insurance; Retirement and Income Solutions through annuities; and foundational Life Insurance products. Geographically, the US segment contributes the largest share of premiums, while Asia offers growth potential, and MetLife utilizes technology and AI-driven underwriting to maintain competitive edges.
The company operates with a significant presence in core markets including the United States, Asia, Europe, Middle East, Africa (EMEA), and Latin America. The business benefits from demographic trends such as aging populations and leverages higher interest rates to boost investment yields, although it faces challenges from rising premiums driven by inflation and catastrophe risks. MetLife's competitive moat is built on brand trust and extensive distribution networks, and the stock offers defensive qualities to portfolios sensitive to Federal Reserve policies regarding interest rates.
While short-term sentiment remains challenged, the analysis notes that MetLife's robust US-centric model and diversified revenue streams provide a degree of resilience in the insurance landscape. The company continues to adapt to sector trends including ESG integration and the need for cyber risk coverage through sustainable investment portfolios. Investors are advised to monitor rate environments and economic indicators as these factors will continue to shape the stock's trajectory alongside broader market pressures affecting peers like Allstate and Prudential.
📉 MetLife shares dropped 2.68% in May, trading at $78.08 amid bearish positioning.
🛡️ Global insurance leader driven by Group Benefits and retirement income solutions.
💰 Leverages AI technology and holds $50B market cap with stable dividends.
📉 MetLife shares declined 2.68% in May 2026, trading at $78.08 as of early May according to StockTitan data.
🛡️ MetLife operates as a global leader in insurance, annuities, and employee benefit programs with significant US market exposure.
🏢 Group Benefits is a primary revenue driver covering dental, disability, accident, and life insurance for millions of US workers.
📅 Retirement and Income Solutions, including annuities, provide steady income streams and appeal to investors seeking defensive assets.
🌍 The company's geographic presence includes the US as its largest premium source, with Asia offering growth potential through expanding middle-class demand.
💰 Investment income from the general account and fee-based revenues enhance margins during favorable interest rate environments.
⚖️ MetLife maintains a top-tier position among peers like Allstate and Prudential with a market capitalization around $50 billion.
🤖 The insurer leverages AI-driven underwriting technology to maintain competitive edges and supports digital transformation efforts.
🌱 ESG integration and cyber risk coverage are key trends shaping the sector, which MetLife addresses through sustainable investment portfolios.
🏦 As a NYSE-listed stock, MetLife offers dividend stability and sensitivity to Federal Reserve policies regarding interest rates.
💼 The company serves individual and institutional customers across segments including the US, Asia, Latin America, Europe, and EMEA.
⚠️ Rising premiums due to inflation and catastrophe risks present industry-wide challenges that MetLife must navigate.
📊 Employment trends are mirrored in the stock's performance via its group benefits segment, acting as a barometer for economic health.
👉 Investors continue to monitor rate environments and broader economic indicators while assessing short-term market pressures.
⚠️ The article includes a disclaimer noting that stocks are volatile financial instruments and the content does not constitute investment advice.
Bullish Signals
MetLife is a global leader in insurance with a strong US focus.
Ticker MET trades on NYSE, key for US retail investors.
Group Benefits drives revenue via dental and life coverage for millions.
Annuities offer steady income streams appealing to defensive investors.
Asia expansion targets growing middle-class demand.
Market cap reached around $50 billion in May 2026.
AI-driven underwriting maintains competitive edges against digital rivals.
ESG principles and cyber coverage adapt to sector trends.
Stock provides dividend stability for volatile markets.
Higher interest rates boost investment yields and margins.
Risk Factors
Shares dropped 2.68% in May 2026 trading at $78.08.
Weekly sentiment weak and bearish positioning may catalyze decline.
Inflation and catastrophe risks drive rising operational premiums.
Stock volatility exposed to unfavorable Federal Reserve rate shifts.
Bullish Signals
MetLife operates as one of the largest providers of insurance, annuities, and employee benefit programs globally, with a strong emphasis on the US market.
The company maintains a significant presence on the NYSE under the ticker MET, making it a key player for US retail investors tracking the insurance sector.
Group Benefits represents a primary revenue driver, contributing through dental, disability, accident, and life coverage for US employers where it covers millions of workers.
Retirement and Income Solutions, including annuities, provide steady income streams, appealing to US investors seeking defensive assets.
Asia provides growth potential through expanding middle-class demand, offering an outlet for the company's expansion strategies.
MetLife holds a top-tier position among peers like Allstate and Prudential, with a market cap reflecting its scale at around $50 billion as of May 2026.
The company invests in AI-driven underwriting to maintain competitive edges against digital transformation efforts by competitors.
MetLife adapts to sector trends through sustainable investment portfolios, integrating ESG principles and cyber risk coverage.
The stock offers dividend stability and acts as a defensive asset for domestic portfolios during market volatility.
Higher interest rates are currently boosting investment yields, which enhances margins in the company's business model.
Risk Factors
MetLife shares experienced a notable decline, dropping 2.68% in May 2026 to trade at $78.08, indicating weakening investor sentiment.
Algorithmic analysis highlights weak near-term sentiment and mid-channel oscillation patterns that could catalyze further bearish positioning for the stock.
The company faces rising operational premiums driven by inflation and increasing catastrophe risks within the US insurance market.
MetLife's performance is highly sensitive to Federal Reserve policies on interest rates, exposing the stock to volatility if rate environments shift unfavorably.
MetLife (NYSE:MET) reported a robust start to its financial year in 2026, with the company highlighting broad-based growth across operating businesses and favorable underwriting trends under its New Frontier strategy. Adjusted earnings for the quarter came in at $1.6 billion, or $2.42 per share, representing an 18% increase from the prior year period, while adjusted earnings per share climbed 23%. The stronger adjusted results were partly attributed to disciplined capital management, although net investment losses from normal trading activity and a modest loss on private equity sales caused reported net income to be lower at $1.1 billion or $1.74 per share. Revenue grew 10% year-over-year excluding pension risk transfers, and return on equity hit the top end of its target range at 17%.
Within specific business segments, Group Benefits saw adjusted earnings rise 19% to $439 million, driven by exceptional life mortality which came in at 80.1%, surpassing its target range of 83% to 88%. Executives noted that this favorability could be influenced by factors such as GLP-1 drugs and potential post-pandemic effects, with MetLife planning to gradually adjust pricing if these trends continue. Retirement and Income Solutions reported an 11% increase in adjusted earnings to $451 million, supported by higher variable investment income and favorable margins, while the company maintains a full-year guidance of $1.6 billion to $1.8 billion for this segment.
International operations also delivered significant growth, with Asia's adjusted earnings surging 31% to $487 million. This expansion was led by strong performance in Japan and Korea; Japan sales increased 26% on a constant currency basis due to a mix of product launches and strength in both yen and dollar products, while Korean sales grew 44% driven by U.S. dollar products. Latin America saw earnings rise 5% year-over-year despite a tax-related headwind in Mexico, and EMEA adjusted earnings jumped 33%, with the company stating that recent geopolitical tensions in the Middle East have not yet had a material impact on its overall operations.
On the investment side, MetLife Investment Management reported an 89% increase in adjusted earnings to $47 million following the first fully integrated quarter after acquiring PineBridge. While institutional client outflows of approximately $2 billion occurred during the quarter due to market volatility and allocation shifts, management indicated that these flows had stabilized later in the quarter and that the pipeline for private assets remained strong. The company is continuing its integration of the two platforms to leverage business growth and favorable expense margins from the combined entity.
📈 Adjusted earnings rose 18% to $1.6B despite net investment losses.
💰 Group Benefits and RIS divisions posted double-digit adjusted earnings growth.
🌏 International Asia and EMEA businesses drove revenue expansion significantly.
⚙️ Strategic capital management under the New Frontier strategy fuels growth.
📈 MetLife reported strong Q1 2026 results with adjusted earnings of $1.6 billion ($2.42/share), an 18% increase from the prior year.
💰 Net income was $1.1 billion ($1.74/share), primarily affected by net investment losses from normal trading and a partial private equity sale.
📊 Adjusted revenue excluding pension risk transfers rose 10%, while return on equity reached 17% at the top end of its target range.
💼 Group Benefits adjusted earnings surged 19% to $439 million, driven by exceptional life mortality and favorable working population trends.
💊 Analysts noted potential mortality drivers like GLP-1 drugs could lead to gradual pricing adjustments if favorability persists long-term.
🏦 Retirement and Income Solutions (RIS) adjusted earnings grew 11% to $451 million, boosted by higher variable investment income and favorable underwriting.
🌏 International businesses showed broad growth, with Asia earning $487 million (up 31%) led by strong sales in Japan and Korea.
📉 Latin America earnings were $229 million but down 9% on a constant currency basis due to tax changes in Mexico.
🚀 EMEA adjusted earnings jumped 33% to $110 million as multi-year sales growth translated into premium increases.
🏢 MetLife Investment Management (including PineBridge) earned $47 million in its first fully integrated quarter, exceeding February outlooks.
💸 Institutional outflows of about $2 billion were observed due to market volatility and platform integration, though the pipeline remains strong.
🇯🇵 Japan sales rose 26% on a constant currency basis, highlighted by a new corporate accident and health product launch.
💰 Korea sales increased 44%, supported by strength in both U.S. dollar and Korean won products amid rising equity markets.
🌍 MetLife stated that current geopolitical situations in the Middle East have not materially impacted EMEA or the company overall.
⚙️ Management emphasized disciplined capital management under its New Frontier strategy as a key driver of top-line growth across all segments.
Bullish Signals
Adjusted earnings rose 18% to $1.6 billion for Q1.
EPS surged 23% to $2.42 via disciplined capital management.
Group Benefits earnings grew 19% on strong mortality ratios.
Group Benefits sales jumped 15% with double-digit voluntary growth.
RIS earnings increased 11% supported by top-end investment spread.
Asia adjusted earnings expanded 31% and Latin America sales up 20%.
Japan sales surged 77% while Korea grew 44%.
PineBridge investment management achieved integrated quarter with $47m earnings.
Outflows stabilized with strong private asset forward commitments.
Risk Factors
MetLife recorded net investment losses from trading activity and private equity sales.
Direct expense ratio at 11.9% remains above the 2026 target of 12.1%.
Core spread declined 4 basis points following asset rotations for pension inflows.
Latin America adjusted earnings dropped 9% due to tax changes in Mexico.
Institutional outflows reached $2 billion driven by volatility and allocation shifts.
Favorable mortality trends may be temporary pull-forward effects rather than structural.
Bullish Signals
MetLife reported adjusted earnings of $1.6 billion for Q1, representing an 18% year-over-year increase driven by broad-based growth across all operating businesses.
Adjusted earnings per share surged 23% to $2.42, reflecting the full earnings power of the company and disciplined capital management under the New Frontier strategy.
Group Benefits adjusted earnings grew 19% to $439 million, aided by exceptional life mortality ratios of 80.1%, which outperformed the annual target range of 83% to 88%.
Group Benefits sales increased 15% driven by double-digit growth in voluntary products and improved persistency, particularly in dental lines.
Retirement and Income Solutions (RIS) delivered adjusted earnings up 11% to $451 million, supported by a total investment spread of 119 basis points at the top end of guidance.
International businesses demonstrated robust expansion with Asia adjusted earnings rising 31% and Latin America sales growing 20% on a constant currency basis.
Asia region sales grew 22% led by strong performance in Japan, where accident and health sales surged 77%, and Korea, which saw a 44% increase in sales.
MetLife Investment Management achieved its first fully integrated quarter after the PineBridge acquisition with adjusted earnings up to $47 million.
Outflows in the investment management business stabilized later in the quarter, and forward commitments remained strong particularly within private assets.
Risk Factors
MetLife incurred net investment losses primarily due to normal trading activity within its fixed maturity portfolio, along with a modest loss tied to the sale of private equity limited partnership interests.
The direct expense ratio improved to 11.9%, which is still above the company's 2026 annual target of 12.1%.
Core spread excluding variable investment income decreased by 4 basis points sequentially as MetLife rotated assets tied to large fourth-quarter pension risk transfer inflows.
Latin America adjusted earnings declined 9% on a constant currency basis, caused by Mexico's value-added tax change and less favorable taxes.
Institutional client outflows amounted to approximately $2 billion during the quarter, driven by market volatility, normal allocation shifts, and integration effects between MetLife and PineBridge.
Potential drivers of favorable mortality trends, such as GLP-1 drugs, may be temporary pull-forward effects rather than sustainable structural changes.
MetLife (MET) shares have recently appreciated by 10.7%, yet Simply Wall St's Excess Returns model suggests the stock remains undervalued at approximately a 57% discount to its intrinsic value of $183.78 per share, based on a recent market price of around $78.82 and a stable book value estimate of $58.06. The analysis utilizes weighted future Return on Equity estimates from eight analysts projecting an average return of 15.86% against a cost of equity, resulting in calculated excess returns that drive the high intrinsic value figure. While traditional metrics like the Price-to-Earnings ratio show the stock trading at 14.81x earnings, which is slightly above the insurance industry and peer averages but nearly identical to Simply Wall St's proprietary Fair Ratio of 14.91x, the valuation gap in the Excess Returns model indicates a significant potential opportunity according to this specific framework. The article highlights that while narrative factors such as international growth or digital transformation could support higher valuations like the $102 analyst target, concerns regarding interest rates and credit risks might anchor expectations closer to the $75 target, illustrating how different investment stories translate into varying fair value estimates.
The content focuses specifically on providing a fundamental data-driven analysis of MetLife's valuation rather than acting as a general market overview or financial advice. It distinguishes between broad industry P/E comparisons and the company-specific Fair Ratio tailored to MetLife's own fundamentals, while emphasizing that its methodology uses historical data and analyst forecasts without factoring in latest price-sensitive announcements. The article concludes with standard disclosures regarding the use of unbiased methodology, the non-advise nature of the commentary, and Simply Wall St's lack of position in the stock, directing readers toward a detailed Company Report for further insights into dividends, insider trades, and financial conditions.
📈 Shares gained 10.7% recently but trail at 3.8% total annual return.
💸 Valuation models suggest a massive 57.1% discount to the current price of $78.82.
⚠️ Trading above industry peers, key risks include interest rates and credit quality.
📉 MetLife shares have recently gained 10.7% but only delivered a 3.8% total return over the last year.
🧮 An Excess Returns model calculates an intrinsic value of $183.78 per share for MetLife.
💸 The current market price is approximately $78.82, suggesting a 57.1% discount to the model's estimate.
📊 MetLife trades at a Price-to-Earnings (P/E) ratio of 14.81x based on current earnings.
🔍 This P/E multiple is higher than both the Insurance industry average (11.18x) and the peer group average (13.20x).
⚖️ Simply Wall St's proprietary Fair Ratio suggests a reasonable P/E of 14.91x, nearly identical to the current price.
🗣️ Investor narratives regarding fair value vary widely, ranging from $75 to $102 per share depending on risk factors and growth potential.
⚠️ The analysis highlights considerations such as interest rates, credit risk, technology execution, and international growth opportunities.
📝 This article utilizes historical data and analyst forecasts without constituting specific financial advice or a recommendation to buy.
Stock trades at 57.1% discount to intrinsic value.
P/E of 14.81x exceeds industry average of 11.18x.
Risk Factors
Market narrative anchors fair value near US$75 due to interest rate, credit risk, and tech execution concerns.
MetLife trades at 14.81x P/E, above the 11.18x industry average and 13.20x peer group averages.
Valuations cite risks of interest rate sensitivity and potential credit quality deterioration.
Bullish Signals
MetLife delivered strong 3.8% returns over the last year, demonstrating performance that competes favorably with the broader Insurance industry.
Based on an Excess Returns model using a book value of $41.69 and stable earnings per share estimate of $9.21, MetLife is estimated to have an intrinsic value of approximately $183.78 per share.
This analysis suggests MetLife is trading at a significant 57.1% discount compared to the recent share price of around $78.82, indicating substantial upside potential.
MetLife trades on a P/E ratio of 14.81x, which is above both the Insurance industry average of 11.18x and the peer group average of 13.20x, suggesting a quality valuation.
Simply Wall St's proprietary Fair Ratio estimate of 14.91x closely aligns with the current P/E of 14.81x, confirming the stock is priced at a fair level based on its specific fundamentals.
Risk Factors
The article explicitly notes that one market narrative anchors MetLife's fair value near the US$75 analyst target due to concerns regarding interest rates, credit risk, and technology execution.
MetLife trades at a P/E of 14.81x, which is above the Insurance industry average of 11.18x and the peer group average of 13.20x, suggesting a potentially richer valuation compared to sector benchmarks.
Analyst forecasts vary widely, with some valuations tied to US$75 specifically citing risks related to interest rate sensitivity and potential credit quality deterioration.
MetLife Stadium in East Rutherford, New Jersey, is currently undergoing installation of a natural grass surface in preparation for hosting eight matches during the upcoming FIFA World Cup, including the final scheduled for July 19. This marks a significant change for the venue, which traditionally utilizes an artificial turf field and houses NFL teams like the New York Giants and Jets. To accommodate the soccer pitch, organizers removed 1,740 seats from the stadium's corners to create necessary space for a longer run-up area required for corner kicks.
The installation process, led by FIFA Senior Pitch Manager David Graham, involved laying down approximately 600 rolls of grass grown in North Carolina on a base layer composed of sand, a permeable cloth called Permavoid, and a ventilation layer. Workers completed the initial phase of installation late on Wednesday night despite minor weather delays, with plans to finish the remainder by late Thursday. This natural grass surface, known as Bermuda grass, is being used alongside other venues in warm climates such as Miami Gardens, Kansas City, and Guadalajara for the expanded 48-nation tournament featuring 104 games across 11 sites in the U.S., Mexico, and Canada.
MetLife Stadium's temporary modifications include altering its field dimensions to meet FIFA standards of 75-by-115 yards, a requirement that some venues ignored during the 1994 World Cup. The NFL teams retain ownership of the stadium but will operate it without their usual football configuration until after the tournament concludes in July. The stadium's record capacity remains 83,367, established during a Jets-Giants game in October 2023, though this is reduced for World Cup matches to suit soccer specifications. The grass rolls were harvested from ten turf farms across North America starting about 10 months ago, emphasizing the global logistics involved in preparing for the major event.
🏟️ MetLife Stadium converts artificial turf to natural Bermuda grass for 2026 World Cup matches.
⚙️ Installation removed 1,740 seats and used 600 rolls harvested from farms across North America.
⚽ The venue hosts the July 19 final after a slight weather delay pushed back work.
🏟️ Workers have begun installing natural grass at MetLife Stadium in East Rutherford, New Jersey.
⚽ The stadium will host eight matches during the 2026 World Cup, including the final on July 19.
🌱 Bermuda grass is being used for warm-season venues, which includes MetLife Stadium.
🚜 Installation began Wednesday and aims to be completed by late Thursday using about 600 rolls.
🚜 Grass was harvested from 10 turf farms across Canada, Mexico, and the U.S. starting 10 months ago.
⚙️ The foundation layers include sand, Permavoid permeable cloth, ventilation layers, and artificial stitching.
🏈 MetLife Stadium is converting its standard artificial turf to natural grass for this event.
📉 1,740 corner seats were removed from the stadium to accommodate a proper soccer field and runup area.
⚽ FIFA requires a 75-by-115 yard pitch, though some venues ignored this rule during the 1994 tournament.
🚛 Fifteen trucks delivered materials to the site in total over the installation period.
☁️ Installation faced a slight weather delay last night but remains on track according to FIFA officials.
🌎 The expanded 2026 tournament features 48 nations, 104 games across 11 sites in the U.S., Mexico, and Canada.
🇺🇸 Six U.S. venues will utilize Bermuda grass while ten others will use cool-season perennials.
❌ Several star players are expected to be absent due to mounting injuries before kickoff.
Bullish Signals
MetLife Stadium hosts the July 19 World Cup final.
Natural grass installation on schedule despite minor delays.
FIFA confirms strong logistical execution with truck arrivals.
Venue previously held record crowd of 83,367 fans.
Tournament features 104 games across 11 diverse North American sites.
New Jersey lowers train fares to $105 for fans.
Over 320 grass rolls installed using advanced stitching.
Risk Factors
MetLife Stadium capacity reduced from 83,367 for October 2023 games.
FIFA ignored pitch standards in 1994, raising enforcement concerns.
Weather delays threaten artificial turf installation and quality.
Stadium faces high pressure transitioning NFL to World Cup in days.
MetLife Stadium hosts final on July 19 amidst tight deadline.
Bullish Signals
MetLife Stadium is preparing for eight World Cup matches, including the highly anticipated final scheduled for July 19.
Installation of natural grass began on schedule, with a clear goal to complete by late Thursday despite minor weather delays.
FIFA Senior Pitch Manager David Graham confirmed that the work is 'going at plan,' highlighting strong logistical execution with multiple truckloads arriving onsite.
Significant preparations are underway at this major venue, which previously hosted a record 83,367 fans for a Jets-Giants game in October 2023.
FIFA utilized two high-quality grass types tailored to specific climate needs, ensuring optimal playing surfaces across all venues.
The tournament will feature an expanded schedule with 104 games involving 48 nations played at 11 diverse sites across North America.
New Jersey has made travel more accessible for fans by lowering train fares to $105 in response to high demand and outcry.
Over 320 rolls of grass were installed at MetLife, utilizing advanced techniques like artificial stitching to ensure a seamless surface.
Risk Factors
MetLife Stadium, typically home of the NFL's New York Giants and Jets with an artificial turf surface, has had 1,740 seats removed from the corners to accommodate a soccer pitch, reducing its record capacity of 83,367 for sports games set in October 2023.
FIFA required a standard 75-by-115 yard pitch for World Cup games, though this requirement was previously ignored by some venues during the 1994 tournament in the U.S., raising potential questions about compliance or enforcement standards.
Installation of the grass field at MetLife Stadium is scheduled to be completed late Thursday, but it faced a slight weather delay last night, introducing risks of further scheduling disruptions or quality concerns for the artificial stitching process involving 600 rolls.
The stadium is one of eight venues in the U.S. hosting World Cup matches, including the final on July 19, placing significant operational pressure on a facility that must transition from NFL to soccer requirements with only limited time remaining before the June 12 kickoff.
MetLife reported strong Q1 2026 adjusted earnings per share growth of 23%, driven by its 'New Frontier' strategy which delivered balanced performance across all operating segments. Group Benefits performance was particularly robust, aided by favorable life mortality trends among the working-age population, a mild flu season, and high persistency within national accounts. The Asia region saw exceptional earnings growth of 31%, fueled by product innovation in Japan and Korea, including new corporate accident and health products and FX-denominated offerings that contributed to overall regional strength.
The investment management segment showed significant improvement following the integration of PineBridge into MetLife Investment Management (MIM), which pushed segment earnings to $47 million, a 68% increase from $28 million in the prior year. This growth occurred despite a structurally higher expense profile as synergies from the acquisition begin to materialize. The company highlighted its technology investments, totaling $3.2 billion over five years, which contributed to a favorable direct expense ratio of 11.9%, demonstrating the effectiveness of AI-driven efficiency initiatives in managing costs while scaling operations.
Outlook for Q2 suggests non-medical health benefit ratios will moderate as seasonal dental utilization and upfront paid family leave claims normalize, with RIS core spreads expected to remain stable or show modest improvement following the rotation of large Q4 pension risk transfer inflows. The company reaffirmed its free cash flow ratio target between 65% and 75%, supported by a substantial $3.9 billion holding company cash buffer and disciplined capital return plans. Additionally, MetLife executed a strategic divestiture of its Ukraine business to allow the franchise to grow under a new regional parent and opportunistically sold $750 million of private equity assets to manage investment allocations while supporting third-party asset management growth.
Management addressed industry-wide challenges regarding seconded employees in Japan, confirming the practice has been discontinued with no material impact on sales or results. The company also raised $1 billion via a subordinated debt issuance that was oversubscribed more than five times to fund its growth strategy. While acknowledging potential headwinds from COVID-19 pull-forward effects and GLP-1 drug impacts, management emphasized MetLife's ability to bundle life with disability and dental products to protect overall margins and maintain pricing flexibility over the long term.
Earnings surged 23% via 'New Frontier' strategy, with Asia rising 31% and MIM gaining 68%.
Strong investments drove $518m income; AI efficiency cut expenses to an 11.9% direct ratio.
Company exited Ukraine, divested PE assets, and maintained FCF payout targets above 65%.
- 💰 MetLife's Q1 2026 adjusted earnings per share grew by 23%, driven by the 'New Frontier' strategy which delivered balanced performance across all operating segments.
- 🏥 Group Benefits results were strengthened by low life mortality in the working-age population, a light flu season, and high persistency within national accounts.
- 🌏 Earnings in the Asia region increased by 31%, primarily due to new corporate accident and health products and foreign exchange-denominated offerings in Japan and Korea.
- 📊 The integration of PineBridge into MetLife Investment Management (MIM) boosted segment earnings to $47 million, a 68% year-over-year increase despite higher expenses.
- 🤖 AI investments totaling $3.2 billion over five years supported efficiency, resulting in a favorable direct expense ratio of 11.9%.
- 📈 Variable investment income reached $518 million, near the high end of expectations, fueled by strong returns in private equity (2.9%) and venture capital (6.8%).
- 🦷 The non-medical health benefit ratio is expected to moderate in H2 2026 as seasonal dental utilization and paid family leave claims normalize.
- 💼 RIS core spreads should remain stable or improve modestly in Q2 following the rotation of large pension risk transfer inflows from Q4.
- 🛡️ The company maintains its free cash flow payout target of 65%-75%, backed by a $3.9 billion holding company cash buffer and disciplined capital return plans.
- 🚀 MIM earnings are expected to improve throughout 2026 as PineBridge integration synergies are realized and the private asset pipeline converts to commitments.
- 📉 While favorable Group Life mortality trends may eventually impact pricing, management expects this adjustment to occur gradually over years rather than quarters.
- 💸 MetLife divested $750 million of private equity assets at a modest discount to support third-party asset management growth and optimize investment allocations.
- 🇺🇦 The company exited its Ukraine business to allow the franchise to grow under a new regional parent entity.
- 🇯🇵 Management resolved the seconded employee issue in Japan by discontinuing the practice, which has had no material impact on sales or financial results.
- 💹 MetLife issued $1 billion in subordinated debt that was oversubscribed more than five times to provide capital for growth initiatives.
- 📉 Outflows of $2 billion were attributed to expected post-PineBridge close activity and typical early-year client allocation shifts, with stabilization noted by April.
- 🏛️ Despite tight spreads, the company is selective in commercial mortgage loan originations while real estate liquidity and price discovery begin to improve.
- 🔄 The firm is pivoting toward asset-backed financing and other private assets where risk-adjusted returns currently outperform traditional real estate loans.
- 🩺 Management cited potential impacts from GLP-1 drugs on health costs but noted they are still researching specific causalities alongside COVID-19 pull-forward effects.
- 💰 The ability to bundle life, disability, and dental products helps protect MetLife's overall margins against future price adjustments in mortality-sensitive lines.
- ⚠️ Management clarified that the seconded employee issue is an industry-wide matter rather than a company-specific problem affecting business momentum.
Bullish Signals
Adjusted EPS grew 23% driven by New Frontier strategy.
Asia earnings surged 31% via Japan and Korea product innovation.
MIM earnings jumped 68% to $47 million after PineBridge integration.
Technology investments of $3.2 billion achieved an 11.9% expense ratio.
Variable income hit $518 million backed by strong private equity returns.
Holding company cash buffer of $3.9 billion supports free cash flow targets.
MetLife oversubscribed a $1 billion debt issuance five times for growth.
MIM earnings expected to improve throughout 2026 post-PineBridge synergies.
Outflows stabilized with a strong diversified international asset pipeline.
Company divested Ukraine business to focus franchise expansion elsewhere.
Risk Factors
Divested $750M private equity at modest discount signaling hard-to-find growth.
$1B debt issuance may signal underlying liquidity constraints or capital pressure.
$2B outflows suggest investor skepticism over PineBridge acquisition integration.
GLP-1 pricing impacts and drug effects pose future revenue concerns.
Tight spreads limit Commercial Mortgage Loan originations and revenue growth.
Bullish Signals
Adjusted EPS grew 23% year-over-year, driven by the 'New Frontier' strategy with balanced and repeatable performance across all segments.
Asia's earnings surged 31% due to product innovation in Japan and Korea, specifically launching new corporate accident and health products and FX-denominated offerings.
The integration of PineBridge into MetLife Investment Management (MIM) propelled segment earnings to $47 million, a 68% increase from $28 million in the prior year.
Technology investments totaling $3.2 billion over five years contributed to a favorable direct expense ratio of 11.9%, demonstrating strong operational efficiency via AI.
Variable investment income reached $518 million, near the top of the expected range, supported by robust private equity returns of 2.9% and venture capital returns of 6.8%.
The company expects its non-medical health benefit ratio to moderate in H2 2026 as seasonal dental utilization and family leave claims normalize.
MetLife successfully executed a $1 billion subordinated debt issuance that was oversubscribed more than five times, providing ample growth capital.
The $3.9 billion holding company cash buffer supports the company's target of maintaining a 65% to 75% free cash flow ratio.
MIM earnings are projected to improve throughout 2026 as integration synergies from the PineBridge acquisition are realized and the private asset pipeline converts.
Management noted that outflows stabilized in late Q1 and April, with a strong, diversified pipeline emerging across international markets post-PineBridge.
The company divested its business in Ukraine to allow the franchise to grow under a new regional parent, enabling focused expansion elsewhere.
MetLife opportunistically managed investment allocations by divesting $750 million of private equity assets to support third-party asset management growth.
Risk Factors
Management divested $750 million of private equity assets at a modest discount, indicating difficulty finding suitable growth opportunities without taking losses.
The company executed a $1 billion subordinated debt issuance to provide growth capital, which may signal underlying liquidity constraints or capital pressure despite the transaction being oversubscribed.
The company reported $2 billion in outflows attributed to post-closing activity and client allocation shifts, which could indicate investor skepticism regarding the new PineBridge acquisition integration.
Management noted that unfavorable pricing impacts from GLP-1 drugs are still under research but acknowledged COVID-19 pull-forward effects and drug impact as potential drivers for future concerns.
The company is being selective in Commercial Mortgage Loan (CML) originations due to tight spreads, limiting revenue growth in a key lending segment despite improving liquidity conditions.
New Jersey Transit has announced a significant reduction in the round-trip train fare for World Cup matches at MetLife Stadium, dropping the price from $150 to $105. This decision was made effective for matches occurring in June and July 2026, with specific sales beginning on May 13 of that year. NJ Transit CEO Kris Kolluri stated that the agency utilized funds from sponsors and other sources to finance this cost reduction rather than burdening taxpayers or commuters. Governor Mikie Sherrill had previously committed that NJ residents would not bear financial costs for FIFA-related transportation, prompting the search for private funding to achieve a price decrease of at least 30%.
The fare adjustment applies only to World Cup matches, which typically require a valid match ticket for purchase, unlike standard round-trip tickets from Penn Station that usually cost $12.90. A total of eight matches are scheduled at the venue, including the club final on July 19, during which the stadium expects approximately 78,000 attendees per game while NJ Transit plans to sell 40,000 train tickets for each event. In addition to the discounted train fare, general parking at MetLife Stadium will not be available; however, limited parking is offered at the nearby American Dream mall with roughly 5,000 spots listed at $225.
Alternative transportation options include shuttle services and park-and-ride lots to alleviate traffic concerns. Round-trip shuttles from Manhattan locations including two points in Manhattan and one at the Port Authority Bus Terminal cost $80, while an eastern park-and-ride located at the Hackensack Meridian School of Medicine offers space for 2,500 vehicles for the same price with drop-offs at designated MetLife parking lots. These logistical details aim to manage the influx of fans attending the tournament while adhering to the financial constraints set by state leadership.
🚄 World Cup train fares drop from $150 to $105 for eight matches.
💰 Funding comes from sponsors and revenue, not taxpayer money.
🅿️ General parking is gone; alternatives include Mall spots at $225 or shuttles for $80.
🚄 NJ Transit has announced a reduction of the round-trip train fare for World Cup matches at MetLife Stadium from $150 to $105.
💰 The price cut was funded entirely by sponsorships and other revenue sources rather than public funds.
🤝 NJ Transit CEO Kris Kolluri confirmed that Governor Mikie Sherrill requested that no financial burden be placed on New Jersey taxpayers or commuters for FIFA-related costs.
📉 Compared to a standard non-event round-trip fare of $12.90, the discounted World Cup price represents an approximately 30% reduction from the original $150 estimate.
🗓️ Eight matches scheduled for June and July at MetLife Stadium will offer this discounted rate on trains.
⚽ Train sales begin on May 13, but passengers must already possess a valid World Cup match ticket to purchase transportation.
🚧 General parking is unavailable at MetLife Stadium for the tournament.
🅿️ Limited parking options are available at the nearby American Dream mall, which offers about 5,000 spots for $225 on the official website.
🚌 Shuttle services will be offered from Manhattan locations and a New Jersey park-and-ride lot for $80 per round-trip pass.
📦 NJ Transit plans to sell up to 40,000 train tickets for each match despite an expected attendance of around 78,000 fans.
Bullish Signals
NJ Transit secured sponsorships to subsidize World Cup train travel.
Round-trip fares dropped over 30% from $150 to $105.
NJ Transit sells only 40k tickets vs 78k expected demand.
General parking at MetLife Stadium is entirely unavailable.
American Dream mall parking limited to 5,000 spots at $225.
Shuttles add $80 fees on top of existing ticket prices.
Bullish Signals
NJ Transit has successfully secured sponsorships and funding from other sources to subsidize the cost of World Cup train travel, allowing for a significant price reduction.
The round-trip fare for fans attending World Cup matches at MetLife Stadium has been lowered by over 30%, dropping from $150 to just $105 per ticket.
New Jersey Governor Mikie Sherrill's commitment to avoiding financial burdens on taxpayers and commuters was honored, ensuring private funding covered these event costs.
NJ Transit plans to sell 40,000 train tickets for each of the eight upcoming matches in June and July to meet high demand from the expected 78,000 fans per game.
Affordable shuttle services are available for $80 round-trip from various Manhattan locations and a park-and-ride site, providing accessible options for attendees arriving by car or bus.
Risk Factors
NJ Transit will sell only 40,000 train tickets for each match despite the venue expecting 78,000 fans per match, creating a significant shortage of official transportation options.
General parking at MetLife Stadium is entirely unavailable for World Cup matches, forcing fans to rely on limited alternative arrangements nearby.
Parking at the nearby American Dream mall is restricted to approximately 5,000 spots and is priced high at $225, limiting accessibility for many attendees.
Shuttle services from key locations like Manhattan and Grand Central cost an additional $80 on top of ticket prices, increasing total travel costs significantly compared to the reduced train fare.
MetLife Inc. (MET) reported first-quarter 2026 results that surpassed analyst expectations across earnings and revenue metrics. Adjusted operating earnings per share reached $2.42, a 7.6% beat against the Zacks Consensus Estimate and representing a 23% year-over-year increase. Operating revenues climbed 4.5% to $19.7 billion, driven by strong investment income of $5.5 billion (up 5%) and solid business volume growth across segments. Group Benefits led performance with earnings up 19%, while International Retirement Solutions (RIS) saw significant PFO growth of 58%, supported by a robust Asian market recovery where earnings jumped 31%.
Despite overall success, higher expenses due to policyholder benefits caused the expense ratio to widen to 20.3%, and specific units faced headwinds. The Corporate & Other unit posted an adjusted loss of $177 million, wider than the prior year's $129 million loss, which offset some gains. Latin America reported earnings that declined 9% on a constant-currency basis due to unfavorable tax-related items, though total PFOs grew 25% on a reported basis. Nevertheless, core business metrics remained resilient with adjusted PFOs of $13.3 billion globally, up 10%.
Looking ahead, MetLife raised its outlook for variable investment income to approximately $1.6 billion for the year and guided Group Benefits PFO growth at 4-7% annually. The company reiterated a target return on equity range of 15-17% and expects double-digit adjusted EPS growth in the near term. Financial position remained strong with cash and equivalents at $22.7 billion, though book value per share fell slightly to $37.92 from the prior year-end figure following share buybacks and dividends.
📈 MetLife EPS beat estimates by 7.6%, rising 23% year over year to $2.42.
⚠️ Gains faced headwinds from higher expenses, Latin American tax issues, and a wider corporate loss.
💵 Cash reserves rose to $22.7 billion while equity decreased slightly to $27.6 billion.
🔄 The company executed $750 million in buybacks and paid $350 million in dividends.
📈 MetLife reported first-quarter 2026 adjusted operating EPS of $2.42, beating analyst estimates by 7.6% and growing 23% year over year.
💰 Adjusted operating revenues increased 4.5% to $19.7 billion, surpassing the consensus mark by 2.4%.
📉 Strong performance was driven by improved net investment income, favorable underwriting, and solid business volume growth across segments.
⚠️ Upside was partially offset by higher expenses, unfavorable tax items in Latin America, and a wider-than-expected loss in the Corporate & Other unit.
💵 Adjusted PFOs reached $13.3 billion, rising 10% year over year when excluding pension risk transfer transactions.
📊 Net investment income grew 5% to $5.5 billion due to asset growth and improved variable investment performance.
🏥 Group Benefits posted adjusted earnings of $439 million, a 19% increase driven by better underwriting and volume growth.
🌏 International segments including RIS, Asia, Latin America, and EMEA all reported double-digit or strong single-digit earnings growth.
💼 MetLife Investment Management saw adjusted earnings surge 68%, though it missed the consensus estimate by 9.2%.
⚠️ Corporate & Other unit incurred an adjusted loss of $177 million, which was wider than the prior year's $129 million loss.
💰 Total expenses rose 2% to $17.6 billion due to increased policyholder benefits and claims costs.
📉 The adjusted expense ratio deteriorated 30 basis points to 20.3%, excluding notable items and PRT adjustments.
⚖️ Net income climbed 29.7% to $1.1 billion, while adjusted return on equity improved to 17%.
💵 Cash and cash equivalents stood at $22.7 billion, up from $22 billion at the end of 2025.
📉 Total assets remained relatively stable at $743.2 billion compared to $745.2 billion at the end of 2025.
💳 Long-term debt decreased slightly to $14.4 billion, while equity totalled $27.6 billion down from $28.7 billion.
🔄 Share buybacks amounted to $750 million in Q1 and approximately $200 million in April 2026.
💸 Dividends paid included $350 million for the quarter under review, with book value per share up 7.8% to $37.92.
MetLife reported first-quarter adjusted EPS of $2.42, beating the Zacks Consensus Estimate by 7.6% with a full-year bottom line advance of 23%.
Adjusted operating revenues improved 4.5% year over year to $19.7 billion, surpassing consensus expectations by 2.4%.
Net investment income grew 5% year over year to $5.5 billion driven by asset growth and improved variable income.
Group Benefits segment earnings rose 19% year-over-year to $439 million, exceeding analyst estimates by 22.5% on strong underwriting results.
RIS unit adjusted earnings advanced 11% year-over-year to $451 million with a significant 58% increase in Adjusted PFOs excluding pension risk transfers.
Asia segment saw adjusted earnings surge 31% year-over-year to $487 million, supported by volume growth and improved investment income.
Latin America delivered strong reported Adjusted PFO growth of 25% year-over-year to $1.9 billion driven by solid business growth and persistency.
EMEA segment recorded a robust 33% year-over-year earnings advance to $110 million fueled by strong volumes and policy renewals.
MetLife Investment Management experienced impressive 68% year-over-year earnings growth to $47 million on back of strong business expansion.
Company cash position strengthened with $22.7 billion in cash and equivalents, up from $22 billion at the end of 2025.
Book value per share increased 7.8% year-over-year to $37.92 as of March 31, 2026.
Management demonstrated confidence with an expectation of double-digit adjusted EPS growth in the near term.
Risk Factors
Higher expenses and unfavorable tax-related items in Latin America partially offset earnings growth.
The loss in the Corporate & Other unit widened to $177 million from $129 million in the prior year quarter.
MetLife's Metlife Investment Management segment missed its Zacks Consensus Estimate by 9.2%.
Total assets declined year over year, dropping from $745.2 billion at the end of 2025 to $743.2 billion as of March 31, 2026.
Total equity contracted from $28.7 billion to $27.6 billion despite share buybacks and dividend payments.
MetLife has raised the expense ratio forecast to 12.1%, indicating potential cost pressures ahead.
Management maintains expectations for a pre-tax variable investment income of around $1.6 billion for 2026, which is below the growth trajectory implied by prior years' results.
MetLife (MET) reported first-quarter earnings that surpassed Wall Street consensus estimates, driven primarily by a 10% increase in net investment income and strong performance within its group benefits segment. The company achieved an adjusted earnings per share of $2.42, exceeding the average analyst expectation of $2.27, which represents a significant improvement over the $1.96 reported for the same quarter last year. This financial result highlights a dual-engine growth strategy where robust investment returns complemented by favorable life underwriting results and volume growth in its group benefits unit successfully lifted overall profitability.
The report specifically notes that the surge in investment income was a key catalyst for beating expectations, suggesting that MetLife's asset management strategies or investment portfolio performance during this period outpaced the broader market or previous quarters. Additionally, the strong showing in the group benefits segment indicates successful expansion or retention within that specific line of business, contributing positively to both underwriting margins and overall revenue streams. These results collectively suggest that MetLife is navigating its current economic environment with diversified growth drivers across investments and core insurance operations.
📈 MetLife Q1 adjusted EPS of $2.42 beat Wall Street estimates.
💰 Net investment income rose 10% year-over-year to drive earnings growth.
👥 Group benefits results strengthened via favorable underwriting and volume gains.
📊 Strong quarterly performance significantly improved upon the previous $1.96 EPS.
MetLife's Q1 adjusted earnings per share came in at $2.42, exceeding the Wall Street consensus estimate of $2.27. 📈
The company reported a 10% year-over-year growth in net investment income as a primary driver of the quarterly beat. 💰
Group benefits results contributed positively, with favorable life underwriting performance and volume growth highlighted. 👥
Previous Q1 EPS of $1.96 serves as a comparison point for the current quarter's improved financial performance. 📊
The report was published on May 6, 2026, by Seeking Alpha author Liz Kiesche. 📅
Bullish Signals
MetLife Q1 EPS reached $2.42, beating estimates.
Net investment income grew 10% to boost profits.
Group benefits saw favorable underwriting and volume growth.
Risk Factors
Sustainable earnings growth relies heavily on non-operable investment income.
Report omits critical revenue growth and expense control metrics.
Bullish Signals
MetLife reported Q1 adjusted earnings per share (EPS) of $2.42, surpassing the average analyst estimate of $2.27 and representing a significant increase from $1.96 in the prior year.
Net investment income grew by 10% during the quarter, providing a substantial tailwind to overall profitability.
The group benefits segment delivered favorable life underwriting results alongside volume growth, contributing positively to the quarter's performance.
Risk Factors
The earnings beat was primarily driven by investment income growth rather than organic business improvements, which may not be sustainable in the current interest rate environment.
The Q1 adjusted EPS of $2.42 barely represents a 23% increase from $1.96 last year, suggesting underlying core operational growth might be limited.
Despite beating estimates, the article focuses almost exclusively on top-line drivers like investment income, leaving out any mention of revenue growth or expense control in the first quarter.
MetLife (NYSE:MET) reported first-quarter fiscal year 2026 financial results that partially missed market expectations. The company posted revenue of $19.07 billion, representing a modest 1.3% year-over-year increase but falling short of the analyst estimate of $19.41 billion. While net premiums earned came in at $12.12 billion, exceeding the consensus of $11.65 billion by about 4%, and non-GAAP profit per share hit $2.42 against an expected $2.27, the report highlighted a significant miss in book value per share. This metric declined by 35% to $37.92, compared to analyst projections of $58.37, reflecting concerns about long-term capital growth relative to liability structures.
The article provides historical context regarding MetLife's revenue trajectory, noting that the company has grown at an annualized rate of 3.2% over the last five years, which is described as sluggish relative to sector benchmarks. However, it highlights a more encouraging trend of 4.4% annualized growth over the last two years. The report emphasizes that net premiums earned constitute roughly 69% of MetLife's revenue, making it the most reliable and consistent source of income compared to investment fees or variable investment returns. Analysts note that while the stock traded flat at $80.22 following the earnings release, management views the current quarter as a single data point within a longer-term quality assessment framework.
Beyond the immediate financial figures, the piece delves into the mechanics of insurance companies as balance sheet businesses where float—the premiums collected before claims are paid—is invested to generate investment income alongside premium revenue. The analysis suggests that Book Value Per Share (BVPS) is a critical metric for evaluating insurers because it captures the residual value of shareholders after accounting for both assets and liabilities, offering a view on long-term capital growth that is harder to manipulate than EPS. Despite the mixed quarter with missed revenue and book value targets, the analysts conclude that earnings performance should be evaluated in conjunction with valuation metrics to determine if MetLife represents a buy opportunity now, directing interested readers to their full research report for deeper actionable insights.
📉 Revenue rose 1.3% to $19.07B, missing analyst estimates of $19.41B.
💰 Adjusted EPS hit $2.42, beating expectations by 6.6% despite missed revenue.
📉 Book value per share dropped 7.1% YoY to $37.92.
📈 Short-term revenue growth improved to 4.4% annually over the last two years.
⚠️ Stock remained flat due to mixed results and lower-than-expected book value.
📉 MetLife's Q1 CY2026 revenue grew 1.3% year-over-year to $19.07 billion, missing analyst estimates of $19.41 billion.
📊 Net premiums earned increased to $12.12 billion, beating expectations due to a lower-than-expected decline in core insurance business volume.
💰 Adjusted earnings per share reached $2.42, surpassing the consensus estimate of $2.27 by 6.6%.
🔻 Book value per share declined 7.1% year-over-year to $37.92, significantly below analyst estimates of $58.37.
💵 The company reported a pre-tax profit margin of 7.9% with total pre-tax profits of $1.51 billion.
🏢 MetLife continues to derive 69.1% of its revenue from core insurance underwriting over the last five years.
📈 Short-term growth has improved, with annualized revenue growth at 4.4% over the last two years compared to a sluggish 3.2% five-year average.
⚠️ The stock remained flat at $80.22 immediately following earnings due to mixed results on book value and revenue metrics.
🕰️ Founded in 1863, this New York-based financial services firm provides insurance, annuities, and asset management globally.
📉 Over the last five years, book value per share declined at a rate of 12.7% annually on a long-term basis.
🚀 Analysts project a massive 70.3% growth in book value per share over the next 12 months to reach $58.37.
📝 Management noted that certain quarters are outliers due to investment gains/losses and do not reflect recurring fundamentals.
🛑 The overall quarter was considered "softer" by analysts because revenue missed targets despite strong earnings per share performance.
🔍 Investors should evaluate MetLife in the context of longer-term business quality alongside current valuation metrics.
Bullish Signals
MetLife profit beat estimates by 6.6% at $2.42/share.
Net premiums hit $12.12B, exceeding forecasts by 4%.
Revenue growth accelerated to 4.4%, above long-term trends.
Book Value projected to grow 70.3% in 12 months.
Risk Factors
Revenue of $19.07B missed estimates by 1.7%.
Net premiums fell 4% year-over-year to $12.12B.
Book value per share dropped 35% vs. estimates.
Five-year revenue growth of 3.2% lags sector.
BVPS missed despite EPS and premium beats.
Bullish Signals
MetLife reported non-GAAP profit of $2.42 per share, which significantly beat analysts' consensus estimates by 6.6%.
Net premiums earned reached $12.12 billion, exceeding analyst estimates of $11.65 billion, driven by a resilient 4% year-on-year beat.
MetLife's two-year annualized revenue growth accelerated to 4.4%, which is above its five-year trend and shows recent improvement.
Over the next 12 months, consensus estimates project MetLife's Book Value per Share to grow by an elite 70.3% to $58.37.
MetLife's global financial services business has maintained a long history of providing insurance, annuities, and asset management since its founding in 1863.
Risk Factors
MetLife's Q1 CY2026 revenue of $19.07 billion missed Wall Street estimates by 1.7%, despite year-over-year growth only reaching a sluggish 1.3%.
Net premiums earned, which historically make up 69.1% of total revenue and serve as the most reliable metric for insurers, declined 4% year over year to $12.12 billion versus analyst expectations.
Book value per share dropped significantly by 35% compared to analyst estimates ($37.92 vs $58.37), indicating potential capital deterioration or valuation compression.
MetLife's five-year annualized revenue growth of 3.2% is described as sluggish and falls below the sector benchmark, raising concerns about its long-term growth baseline.
The company missed analyst consensus estimates for the key metric of Book Value per Share (BVPS), even though it beat estimates on EPS and Net Premiums Earned.
Despite beating profit estimates, the overall quarter was characterized as 'softer' due to the miss in top-line revenue and significant underperformance in BVPS relative to projections.
We use cookies to run the site and, only if you allow it, for live chat, analytics, personalization and ad measurement.
We use cookies to:
Deliver and maintain our services, protect against spam, fraud and abuse
Offer a live chat with our team (Enuchat, optional)
Measure audience engagement and site statistics to understand how our services are used (Google Analytics, optional)
Remember your quiz progress and tailor the knowledge base to your skill level (optional)
Measure how our ads on Facebook and Instagram perform, including whether a visit leads to a confirmed sign-up, matched to your Facebook or Instagram account using hashed contact details you enter (Meta Pixel, optional)
Optional cookies are only set if you allow them. You can accept all, reject all or choose per category, and change your choice at any time via the "Manage Cookies" link in the footer. Google and Meta may process this data in the USA. More in our Privacy Policy.
Manage cookie preferences
Necessary cookiesAlways active
Required for the website to function. These cannot be disabled.
Cookie
Purpose
Duration
PHPSESSID
Session identifier for login, security tokens, and site functionality
Session
cookie_consent
Stores your cookie preferences
1 year
Functional cookies
Show the live chat button so you can message our team. The Enuchat chat widget stores a visitor ID in your browser and sends your chat messages to Enuchat. When this is off, the chat is not loaded.
Cookie
Purpose
Duration
enuchat_visitor_id
Keeps your chat conversation linked to this browser (Enuchat, browser storage)
Until you clear it or turn this off
Analytics cookies
Help us understand how visitors use our website with Google Analytics, provided by Google LLC. Google receives pages visited, device data and an IP address, and may process them in the USA. If you also allow marketing cookies, the Google tag can detect contact details you enter or see on our pages, such as your email address, phone number, name or address, hash them before sending and pass them to Google so it can match your visits to a Google account for measuring our ads. Hashed details are still personal data. See how Google uses information from sites that use its services.
Cookie
Purpose
Duration
_ga
Distinguishes unique visitors (Google Analytics)
2 years
_ga_*
Maintains session state (Google Analytics)
2 years
Personalization cookies
Remember your quiz progress and work out your investing level so we can recommend knowledge-base articles and the right reading depth for you. Stored only on your device.
Cookie
Purpose
Duration
bes_user_level
Your quiz-derived investing level, used to tailor content
1 year
Marketing cookies
Let Meta (Facebook and Instagram) measure how our ads perform, using the Meta Pixel. Meta Platforms Ireland Ltd. receives the pages you visit and, when you confirm the email address of a new account, a "completed registration" event, together with browser identifiers and your IP address. Meta's automatic advanced matching also reads contact details you type into forms on our site, such as your email address or name, hashes them in your browser and sends them with these events so Meta can match them to a Facebook or Instagram account. Hashed details are still personal data. These events are sent from your browser and may also be forwarded to Meta through Meta's Conversions API Gateway. Our own server also sends page visits and completed-registration events directly to Meta's Conversions API, with your IP address, browser user agent and Meta browser identifiers, so Meta can count it once. To help Meta match these visits, your browser and our server also send a random visitor ID from our own cookie and, if you are signed in, your account ID, your confirmed email address and the name, city, postal code and country saved in your profile, all hashed first. We and Meta are joint controllers for collecting and sending this data, and Meta's further use, which may include processing in the USA, is described in the Meta Privacy Policy. When this is off, the Meta Pixel is not loaded and no page visit or registration event is sent to Meta. Together with analytics cookies, this choice also lets Google receive hashed contact details, as described under Analytics cookies.
Cookie
Purpose
Duration
_fbp
Identifies browsers for Meta ad measurement (Meta Pixel)
3 months
_fbc
Stores the Meta ad click that brought you here (Meta Pixel)
3 months
_bes_meid
Random visitor ID, sent to Meta only hashed, so your visits can be matched (Meta Pixel and Conversions API)